Donald A Podoloff

Summary

Affiliation: Texas Medical Center
Country: USA

Publications

  1. ncbi request reprint PET/CT and occult primary tumors
    Donald A Podoloff
    Division of Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Natl Compr Canc Netw 7:239-44. 2009
  2. ncbi request reprint Diagnostic and therapeutic applications of radiolabeled somatostatin analogs: current status in an oncology center
    Donald A Podoloff
    Texas Medical Center, Nuclear Medicine, Box 83, 1515 Holcombe Boulevard, Houston, Texas, 77030 4095, USA
    Curr Pharm Des 8:1809-14. 2002
  3. ncbi request reprint PET and PET/CT in management of the lymphomas
    Donald A Podoloff
    Division of Diagnostic Imaging, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Radiol Clin North Am 45:689-96, vii. 2007
  4. ncbi request reprint We should desist using RECIST, at least in GIST
    Robert S Benjamin
    Department of Sarcoma Medical Oncology and the Division of Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:1760-4. 2007
  5. pmc Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer
    Naomi R Schechter
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, 77030, USA
    Eur J Nucl Med Mol Imaging 36:1583-91. 2009
  6. ncbi request reprint Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer
    Jeong Geun Yi
    Department of Radiology, Division of Diagnostic Imaging, University of Texas M D Anderson Cancer Center, Box 57, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Radiology 236:271-5. 2005
  7. ncbi request reprint Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria
    Haesun Choi
    Division of Diagnostic Imaging and Department of Sarcoma Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:1753-9. 2007
  8. ncbi request reprint Interobserver and intraobserver variability of standardized uptake value measurements in non-small-cell lung cancer
    Edith M Marom
    Departments of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Thorac Imaging 21:205-12. 2006
  9. ncbi request reprint Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck
    Naomi R Schechter
    Division of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Nucl Med 45:1683-7. 2004
  10. ncbi request reprint Incidental findings on integrated PET/CT that do not accumulate 18F-FDG
    John F Bruzzi
    Department of Thoracic Imaging, M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0371, Houston, TX 77030 4095, USA
    AJR Am J Roentgenol 187:1116-23. 2006

Detail Information

Publications39

  1. ncbi request reprint PET/CT and occult primary tumors
    Donald A Podoloff
    Division of Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Natl Compr Canc Netw 7:239-44. 2009
    ..This article reviews the available literature, attempts to place PET/CT using F-18-labeled FDG in clinical perspective and compares the combined modality with conventional anatomic imaging technologies...
  2. ncbi request reprint Diagnostic and therapeutic applications of radiolabeled somatostatin analogs: current status in an oncology center
    Donald A Podoloff
    Texas Medical Center, Nuclear Medicine, Box 83, 1515 Holcombe Boulevard, Houston, Texas, 77030 4095, USA
    Curr Pharm Des 8:1809-14. 2002
    ..The principles of Somatostatin Receptor Imaging and radiotherapy are discussed in this article along with the current status of these modalities in clinical practice as viewed by the author...
  3. ncbi request reprint PET and PET/CT in management of the lymphomas
    Donald A Podoloff
    Division of Diagnostic Imaging, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Radiol Clin North Am 45:689-96, vii. 2007
    ..The impact on patient outcome is not clear, however, because no controlled trials have yet been conducted and follow-up periods are generally short...
  4. ncbi request reprint We should desist using RECIST, at least in GIST
    Robert S Benjamin
    Department of Sarcoma Medical Oncology and the Division of Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:1760-4. 2007
    ..This study was designed to validate these observations in an independent data set...
  5. pmc Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer
    Naomi R Schechter
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, 77030, USA
    Eur J Nucl Med Mol Imaging 36:1583-91. 2009
    ..To assess the radiation dosimetry and biodistribution of (99m)Tc-labeled ethylene dicysteine deoxyglucose ((99m)Tc-EC-DG) in patients with non-small-cell lung cancer (NSCLC)...
  6. ncbi request reprint Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer
    Jeong Geun Yi
    Department of Radiology, Division of Diagnostic Imaging, University of Texas M D Anderson Cancer Center, Box 57, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Radiology 236:271-5. 2005
    ....
  7. ncbi request reprint Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria
    Haesun Choi
    Division of Diagnostic Imaging and Department of Sarcoma Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:1753-9. 2007
    ....
  8. ncbi request reprint Interobserver and intraobserver variability of standardized uptake value measurements in non-small-cell lung cancer
    Edith M Marom
    Departments of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Thorac Imaging 21:205-12. 2006
    ..To assess interobserver and intraobserver variabilities in measuring the maximal standardized uptake value (SUV) of non-small-cell lung cancer...
  9. ncbi request reprint Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck
    Naomi R Schechter
    Division of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Nucl Med 45:1683-7. 2004
    ..This study assessed the radiation dosimetry of 99mTc-labeled ethylene dicysteine (EC) C225 (EC-C225), a promising radioligand for functional tumor imaging...
  10. ncbi request reprint Incidental findings on integrated PET/CT that do not accumulate 18F-FDG
    John F Bruzzi
    Department of Thoracic Imaging, M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0371, Houston, TX 77030 4095, USA
    AJR Am J Roentgenol 187:1116-23. 2006
    ..The purpose of this study was to report the prevalence of abnormalities that do not show increased 18F-FDG uptake on the CT component of integrated PET/CT in patients with non-small cell lung cancer...
  11. ncbi request reprint Truncation artifact on PET/CT: impact on measurements of activity concentration and assessment of a correction algorithm
    Osama Mawlawi
    Department of Imaging Physics, M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 56, Houston, TX 77030, USA
    AJR Am J Roentgenol 186:1458-67. 2006
    ..The purposes of this study were to evaluate the impact of this artifact on measurements of 18F-FDG activity concentrations and to assess a truncation correction algorithm...
  12. ncbi request reprint Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation
    Osama Mawlawi
    Department of Imaging Physics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 56, Houston, TX 77030, USA
    AJR Am J Roentgenol 186:308-19. 2006
    ..The objective of this study was to quantify the effect of IV contrast media in PET/CT and assess its impact on patients with intrathoracic malignancies...
  13. ncbi request reprint Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT
    Mylene T Truong
    Division of Diagnostic Imaging, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 57, Houston, TX 77030, USA
    AJR Am J Roentgenol 183:1127-32. 2004
    ..The purpose of this study was to determine the prevalence, location, and appearance of hypermetabolic brown fat in the mediastinum...
  14. ncbi request reprint Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow
    Toshiki Kazama
    Division of Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Eur J Nucl Med Mol Imaging 32:1406-11. 2005
    ..The purpose of this study is to evaluate the effects of CSF, conventional-or high-dose chemotherapy on bone marrow FDG uptake...
  15. ncbi request reprint Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications
    Jeremy J Erasmus
    Departments of Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, Houston, Tex, USA
    J Thorac Cardiovasc Surg 129:1364-70. 2005
    ..We evaluate the use of integrated computed tomography-positron emission tomography in patients with malignant pleural mesothelioma who are being considered for extrapleural pneumonectomy...
  16. ncbi request reprint Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer
    Shi Ming Tu
    Department of Genitourinary Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Clin Adv Hematol Oncol 8:341-51. 2010
    ....
  17. ncbi request reprint The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia
    Isis W Gayed
    Department of Nuclear Medicine, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Nucl Med 46:248-52. 2005
    ....
  18. doi request reprint Imaging of gastrointestinal stromal tumors and assessment of benefit from systemic therapy
    Piyaporn Boonsirikamchai
    Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Hematol Oncol Clin North Am 23:35-48, vii. 2009
    ..The roles of MRI and ultrasound are also described...
  19. ncbi request reprint [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer
    Ryohei Sasaki
    Department of Radiation Oncology, Unit 97, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Clin Oncol 23:1136-43. 2005
    ..To determine whether the standardized uptake value (SUV) of [(18)F]fluorodeoxyglucose uptake by positron emission tomography could be a prognostic factor for non-small-cell lung cancer (NSCLC)...
  20. ncbi request reprint CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings
    Haesun Choi
    Department of Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    AJR Am J Roentgenol 183:1619-28. 2004
    ....
  21. pmc Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates
    Scott E Woodman
    Department of Melanoma Medical Oncology and Department of Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    Mol Cancer Ther 8:2079-85. 2009
    ..These data support the selective inhibitory effect of dasatinib against cells harboring the most common KIT mutation in melanoma, and thus has therapeutic implications for acrallentiginous, chronic sun-damaged, and mucosal melanomas...
  22. ncbi request reprint NCCN task force: clinical utility of PET in a variety of tumor types
    Donald A Podoloff
    The University of Texas, M D Anderson Cancer Center, Houston, Texas, USA
    J Natl Compr Canc Netw 7:S1-26. 2009
    ..This report summarizes the proceedings of this meeting, including discussions of the background of PET, the role of PET in oncology, principles of PET use, emerging applications, and possible future developments...
  23. ncbi request reprint Assessment of antiangiogenic effect using 99mTc-EC-endostatin
    David J Yang
    Department of Nuclear Medicine, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer Biother Radiopharm 17:233-45. 2002
    ..The purpose of this study was to develop 99mTc-ethylenedicysteine-endostatin (99mTc-EC-endostatin) for the evaluation of anti-angiogenesis therapy...
  24. ncbi request reprint Whole-body lymphoscintigraphy using transmission scans
    Martha Vallejo Mar
    Department of Nuclear Medicine, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Nucl Med Technol 30:12-7. 2002
    ..This technique should decrease scanning time, help locate the sentinel lymph node, and decrease radiation exposure to the technologist...
  25. ncbi request reprint Assessment of cyclooxygense-2 expression with 99mTc-labeled celebrex
    David J Yang
    Division of Diagnostic Imaging, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Anticancer Drugs 15:255-63. 2004
    ..5 to 4 h in tumor-bearing animal models. We conclude that Tc-EC-CBX may be useful to assess tumor COX-2 expression. This may be useful in the future for selecting patients for treatment with anti-COX-2 agents...
  26. ncbi request reprint Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials
    Gregory A Wiseman
    Nuclear Medicine, Department of Radiology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    J Nucl Med 44:465-74. 2003
    ..Dosimetry and pharmacokinetic data from 4 clinical trials of (90)Y-ibritumomab tiuxetan RIT for relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL) were combined and assessed for correlations with toxicity data...
  27. ncbi request reprint Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy
    Shi Ming Tu
    Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA
    J Clin Oncol 23:7904-10. 2005
    ..We assessed the rate of bone marrow failure in patients with prostate cancer who had received a dose of strontium-89...
  28. ncbi request reprint Bone imaging in metastatic breast cancer
    Tsuyoshi Hamaoka
    Breast Cancer Research Program, Department of Blood and Marrow Transplantation, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 448, Houston, TX 77030, USA
    J Clin Oncol 22:2942-53. 2004
    ....
  29. ncbi request reprint Teflon injection for vocal cord paralysis: false-positive finding on FDG PET-CT in a patient with non-small cell lung cancer
    Mylene T Truong
    Department of Diagnostic Radiology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 57, Houston, TX 77030, USA
    AJR Am J Roentgenol 182:1587-9. 2004
  30. ncbi request reprint Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes
    Osama Mawlawi
    Department of Imaging Physics, M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Nucl Med 45:1734-42. 2004
    ..7 and 70 cm, respectively. The scanner has a uniform patient port of 70 cm throughout the PET and CT FOV, and the PET scanner is equipped with retractable septa to allow 2D and 3D imaging...
  31. ncbi request reprint Case 69: extramedullary hematopoiesis
    Haesun Choi
    Divisions of Diagnostic Imaging and Pathology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, PO Box 57, Houston, TX 77030, USA
    Radiology 231:52-6. 2004
  32. ncbi request reprint Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents
    David J Yang
    Division of Diagnostic Imaging, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Radiology 226:465-73. 2003
    ..To evaluate the feasibility of technetium 99m ((99m)Tc) ethylenedicysteine-deoxyglucose (ECDG) imaging in tumor-bearing rodents...
  33. ncbi request reprint Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V
    Shi Ke
    Division of Diagnostic Imaging, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Nucl Med 45:108-15. 2004
    ..In this study, we evaluated the imaging properties of an (111)In-labeled, long-circulating annexin V...
  34. ncbi request reprint Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody
    Naomi R Schechter
    Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston 77030, USA
    Anticancer Drugs 14:49-56. 2003
    ..5 to 4 h in tumor bearing rodents. We conclude that 99mTc-EC-C225 may be useful to assess tumor EGFR expression. This may be useful in the future for selecting patients for treatment with C225...
  35. ncbi request reprint Radiation dosimetry results from a Phase II trial of ibritumomab tiuxetan (Zevalin) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopenia
    Gregory A Wiseman
    Mayo Clinic, Rochester, MN 55905, USA
    Cancer Biother Radiopharm 18:165-78. 2003
    ..These correlations were not consistent across the total patient population, and therefore, could not be exploited to predict hematologic toxicity...
  36. ncbi request reprint Lymphomatous involvement of gastrointestinal tract: evaluation by positron emission tomography with (18)F-fluorodeoxyglucose
    Sith Phongkitkarun
    Department of Radiology, Faculty of Medicine, Ramathibodi Hospital, Rama VI Road, Rajchathewi, Bangkok 10400, Thailand
    World J Gastroenterol 11:7284-9. 2005
    ....
  37. ncbi request reprint NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer
    Donald A Podoloff
    J Natl Compr Canc Netw 5:S1-22; quiz S23-2. 2007
    ..This report summarizes the proceedings of this meeting, including discussions of the background of PET, possible future developments, and the role of PET in oncology...
  38. ncbi request reprint American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer
    Gary H Lyman
    University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
    J Clin Oncol 23:7703-20. 2005
    ..To develop a guideline for the use of sentinel node biopsy (SNB) in early stage breast cancer...
  39. ncbi request reprint Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results
    Barry A Siegel
    Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    J Nucl Med 44:700-7. 2003
    ..We report here the initial clinical study of such an agent, (111)In-diethylenetriaminepentaacetic acid (DTPA)-folate, evaluated for diagnosis of ovarian malignancy...